August 4, 2025

Lantheus Holdings, Inc. (LNTH) Investor Outlook: Exploring a 76% Potential Upside with Strong Buy Ratings

Investors looking for promising opportunities in the healthcare sector might want to pay close attention to Lantheus Holdings, Inc. (NASDAQ: LNTH). With a robust portfolio of diagnostic and therapeutic products..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A 32% Potential Upside in Biotech Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising portfolio of genetic medicines. Headquartered in Pittsburgh, Pennsylvania, this..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Healthcare Game Changer with a 5.93% Upside Potential

iRhythm Technologies, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector with its innovative approach to cardiac monitoring. As a leader in the medical devices industry, iRhythm is reshaping..

Bruker Corporation (BRKR) Stock Analysis: Navigating a 44% Potential Upside Amidst Market Volatility

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector specializing in medical devices, has caught the attention of investors with its intriguing financial metrics. As of the latest..

Waystar Holding Corp. (WAY) Stock Analysis: A 41.57% Potential Upside and Strong Buy Ratings Propel Healthcare IT Specialist

Waystar Holding Corp. (NASDAQ: WAY) is making waves in the healthcare IT sector, having carved out a niche with its innovative cloud-based payment solutions. With a market cap of $6.2..

HealthEquity, Inc. (HQY) Stock Analysis: Promising 34% Upside Potential Sparks Investor Interest

In the dynamic landscape of healthcare services, HealthEquity, Inc. (NASDAQ: HQY) emerges as a compelling investment opportunity, particularly for those eyeing robust growth potential. As a leader in the health..

Verona Pharma plc (VRNA) Stock Analysis: Exploring the 0.99% Potential Upside in the Biotech Sector

Verona Pharma plc (NASDAQ: VRNA), a UK-based biopharmaceutical powerhouse, has become a focal point of interest in the healthcare sector, particularly within the biotechnology industry. With its current market capitalization..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring the 50% Upside Potential for Investors

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, is currently making waves in the investment community with its robust pipeline of innovative treatments and an enticing..

Telix Pharmaceuticals Limited (TLX): Investor Outlook and Potential 73.33% Upside

Telix Pharmaceuticals Limited (TLX), a dynamic player in the biotechnology sector, is making waves with its innovative approach to therapeutic and diagnostic radiopharmaceuticals. With a market capitalization of $4.37 billion,..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Biotech Innovator Poised for 30% Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a standout in the biotechnology sector, is drawing significant attention from investors with its robust pipeline of transformative medicines targeting genetic diseases and cancers. As..

Glaukos Corporation (GKOS) Investor Outlook: A 42.85% Upside Amidst Promising Growth in Medical Devices

Glaukos Corporation (NYSE: GKOS), a pioneering player in the healthcare sector, is captivating investor interest with its robust growth prospects and a substantial potential upside of 42.85%. As a leading..

Bausch + Lomb (BLCO) Stock Analysis: Exploring a Potential 11% Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector with a rich history dating back to 1853, presents a compelling investment case for those looking to diversify..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 10.28% Upside in the Healthcare Information Sector

Doximity, Inc. (NYSE: DOCS) stands as a prominent player within the healthcare information services industry, offering a specialized digital platform that caters to medical professionals across the United States. With..

Penumbra, Inc. (PEN) Investor Outlook: Strong Buy Ratings and 27.93% Potential Upside Highlight Growth Potential

Penumbra, Inc. (NYSE: PEN) stands as a pivotal player in the healthcare sector, specifically within the medical devices industry. Based in Alameda, California, Penumbra has made significant strides in designing..

Prestige Consumer Healthcare (PBH) Stock Analysis: 18.92% Potential Upside Amid Solid Performance

Prestige Consumer Healthcare Inc. (PBH), a key player in the healthcare sector, is garnering attention from investors due to its robust performance and significant growth potential. With a market capitalization..

DaVita Inc. (DVA) Stock Analysis: Navigating a 15.9% Upside Amidst a Shifting Healthcare Landscape

DaVita Inc. (NYSE: DVA) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $10.47 billion, DaVita is a..

The Ensign Group, Inc. (ENSG) Stock Analysis: Unveiling a 12.9% Potential Upside for Healthcare Investors

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, operates within the medical care facilities industry in the United States. With a market capitalization of $8.76..

Elanco Animal Health (ELAN) Stock Analysis: Potential 16% Upside Amid Strong Analyst Ratings

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a significant player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic animal health products. With..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a Robust Revenue Growth of 42.20%

Oscar Health, Inc. (OSCR), a key player in the healthcare plans industry, is drawing attention from investors with its impressive revenue growth of 42.20%, despite the challenges reflected in its..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 65% Upside Potential with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (BMRN), a key player in the biotechnology sector, is garnering significant attention from investors due to its promising upside potential. With a market capitalization of $11.15 billion,..

Search

Funds

August 4, 2025

Search

Funds

August 4, 2025

FTSE 100

Funds